Lumella Preeclampsia Test System
A rapid, accessible diagnostic tool for assessing preeclampsia risk where laboratory infrastructure is limited.
Maternal diagnostics
Overview
A rapid, accessible diagnostic tool for assessing preeclampsia risk where laboratory infrastructure is limited.
The Lumella system provides semi-quantitative measurement of glycosylated fibronectin (GlyFN) in fingerstick whole blood to assess the risk of pre-eclampsia during pregnancy. It is designed for use at HCIII and HCIV level, giving antenatal teams an objective screening result within minutes.
Objectives
- Strengthen antenatal screening for preeclampsia
- Enable early detection at HCIII / HCIV level
- Improve clinical management of at-risk mothers
- Enhance referral systems and emergency care
- Increase community awareness
- Build data systems for monitoring & evaluation
Key characteristics
Accuracy
Precision
Sensitivity
Specificity
Limit of Detection / Quantitation
Stability
Other projects
Point-of-care imaging
Clarius Portable Ultrasound
High-resolution diagnostic imaging for remote and resource-limited maternity settings.
View project
Blood grouping
Eldon Blood Typing
An easy, fast and reliable finger-prick solution for determining blood groups anywhere.
View project